Bliss Gvs Share Price (BLISSGVS)
Check the latest share price of Bliss Gvs, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
NSE
Bliss Gvs Stock Performance
Get live Bliss Gvs share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
₹143.25Day's Price Range₹153.352 Week's Low
52 Week's High
₹101.0152-Week Price Range₹185.5
| Returns % | |
| 1 Month Return | + 25.54 % |
| 3 Month Return | + 32.82 % |
| 1 Year Return | + 41.05 % |
| 3 Year Return | + 93.64 % |
| 5 Year Return | + 40.65 % |
| Market Stats | |
| Previous Close | ₹148.43 |
| Open | ₹146.99 |
| Volume | 7.79L |
| Upper Circuit | ₹178.11 |
| Lower Circuit | ₹118.74 |
Bliss Gvs Fundamentals & Key Indicators
Check Bliss Gvs market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,573.18 Cr
Return on Equity (ROE)
7.91
PE Ratio (TTM)
18.62
Return on capital employed (ROCE)
11.19
Industry PE ratio
57.39
Beta (LTM)
1.18
P/B Ratio
1.19
Dividend Yield
0.44
PEG Ratio
23.56
Quarterly Earnings Growth YOY
-439.1
EPS (TTM)
7.79
Sector
Pharmaceuticals
Book Value
92.38
Technical Analysis
Bullish
View Technical Analysis
How to invest in Bliss Gvs?
Investing in Bliss Gvs is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Bliss Gvs or BLISSGVS on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Bliss Gvs or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Bliss Gvs with just a few clicks!
Bliss Gvs Stock's Interest Amongst Investors
Bliss Gvs Valuation
Track how Bliss Gvs P/E has moved over time to understand its valuation trends.
Bliss Gvs in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (18.62x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (576.11x)
January 3, 2022
Today’s Price to Earnings Ratio: 18.62x
Bliss Gvs Financial Results
Get the annual and quarterly financial summary of Bliss Gvs, including revenue, profit, loss and more.
Indices Featuring Bliss Gvs Stock
Check stock indices that include Bliss Gvs.
Bliss Gvs Earnings and Dividends
View detailed summary of the earnings and dividend history of Bliss Gvs.
Bliss GVS Pharma Ltd Earnings Results
Bliss GVS Pharma Ltd’s net profit jumped 269.84% since last year same period to ₹15.54Cr in the Q4 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -34.71% fall in its net profits since last 3-months.
Read More about Earnings ResultsBliss GVS Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.67%.
Read More about Dividends
Bliss Gvs Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Bliss Gvs.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.29% | 0.00 | |
| Foreign Institutions | 13.18% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 44.98% | 0.00 | |
| Others | 6.55% | 0.00 |
Bliss Gvs vs Peers
Compare market cap, revenue, PE, and other key metrics of Bliss Gvs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,573.18 | 8.13% | 0.54 | 81 | 770 | |
| NA | 6.24 | 5.19% | 5.69 | NA | NA | |
| NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
| NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
| NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Bliss Gvs News & Key Events
Latest news and events in one place to help you make informed investing decisions in Bliss Gvs.
Bliss GVS Transfers Stake in Greenlife Healthcare - 13 May, 2025
On May 13, 2025, Bliss GVS Pharma announced the transfer of its entire 51% stake in Greenlife Bliss Healthcare to Greenlife Pharmaceuticals. Financial results showed mixed performance, with standalone net sales down 4.77% year-on-year, while consolidated net profit surged 269.87%. Shares closed at Rs. 118.77.Bliss GVS Pharma Initiates Arbitration for Dues Recovery - 03 May, 2025
Bliss GVS Pharma has invoked arbitration against Pan Pharmaceuticals in Kenya to recover outstanding dues of approximately USD 1.69 million. The company has made provisions in its accounts to mitigate financial impact, with the claim's outcome dependent on arbitration results.Bliss GVS Pharma Receives USFDA Approval for Mesalamine - 15 Apr, 2025
Bliss GVS Pharma's partner, Rising Pharma Holdings, has received USFDA approval for Mesalamine Suppositories 1000 mg. This approval enhances Bliss GVS's U.S. portfolio and reflects its growing R&D capabilities, addressing a niche market worth USD 29 million by January 2025.
Insights on Bliss GVS Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, BLISSGVS stock has moved up by 9.9%
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 35.10% to 35.29% in Mar 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 44.84% to 44.98% in Mar 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 37.4%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 4.2%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 2 quarters, 225.68 Cr → 210.05 Cr (in ₹), with an average decrease of 6.9% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 13.51% to 13.18% in Mar 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 3 quarters, 24.26 Cr → 15.54 Cr (in ₹), with an average decrease of 18.3% per quarter
About Bliss Gvs
Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.
To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.
Revenue: ₹197.99Cr as on March 2025 (Q4 FY25)
Net Profit: ₹16.65Cr as on March 2025 (Q4 FY25)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
| Organisation | Bliss GVS Pharma Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Subramanian R Vaidya |
| E-voting on shares | Click here to vote |
Mutual Funds that own Bliss Gvs
Check out the Mutual Funds with significant holdings in Bliss Gvs.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Bandhan BSE Healthcare Index Fund Direct Growth | 0.07% |
FAQs
What is Bliss Gvs share price today?
Bliss Gvs share price today stands at ₹149.3, Open: ₹146.99, Previous Close: ₹148.43, High: ₹153.3, Low: ₹143.25, 52 Week High: ₹185.5, 52 Week Low: ₹101.01.
What is today's traded volume of Bliss Gvs?
Today's traded volume of Bliss Gvs is 7.79L. Which means that 7.79L shares of Bliss Gvs were bought and sold on the stock market during today's trading session.
What is Bliss Gvs's market cap today?
Today's market capitalisation of Bliss Gvs is ₹1,573.18 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Bliss Gvs?
Bliss Gvs’s 52 week high is ₹185.5 and 52 week low is ₹101.01. The current share price of Bliss Gvs is ₹149.3, which is -19.51% down from its 52 week high and 47.81% up from its 52 week low.